Aurobindo pharma along with its promoters settled an insider trading case with the capital market regulator SEBI by paying over Rs. 22 crore as settlement charges. The reason for paying this settlement charge is that Aurobindo Pharma and its promoters and three other entities were fined by SEBI of Rs. 22.7 crore for indulging in insider trading between July 2008 and March 2009. SEBI in the settlement order stated that the enforcement proceedings are disposed of and it would not initiate enforcement action against the company and others for the said defaults.

Click on the icon to read more: